(BHVN) Biohaven Pharmaceutical complete technical analysis [charts+indicators] | Buy/Sell Biohaven Pharmaceutical | (BHVN) share price targets
Complete technical analysis of Biohaven Pharmaceutical (BHVN) by charts plus indicators, forecast predictions and share price targets for Biohaven Pharmaceutical (BHVN)
Biohaven Pharmaceutical trades in USA in Health Care sector.
Showing technical analysis as on 2025-10-31 View latest technical analysis
10 day averaged volume of Biohaven Pharmaceutical is 1961044
| Date | Daily Closing Price | Open | High | Low | Volume | 
| 31 Fri Oct 2025 | 17.20 | 17.20 | 17.84 | 16.90 | 1.241 times | 
| 31 Fri Oct 2025 | 17.20 | 17.20 | 17.84 | 16.90 | 1.241 times | 
| 30 Thu Oct 2025 | 17.39 | 17.92 | 18.57 | 17.35 | 0.916 times | 
| 29 Wed Oct 2025 | 18.11 | 17.00 | 18.40 | 16.80 | 1.116 times | 
| 28 Tue Oct 2025 | 17.20 | 17.05 | 17.72 | 16.90 | 0.866 times | 
| 27 Mon Oct 2025 | 17.39 | 16.90 | 17.83 | 16.90 | 0.981 times | 
| 24 Fri Oct 2025 | 16.60 | 16.60 | 17.00 | 16.40 | 0.653 times | 
| 23 Thu Oct 2025 | 16.30 | 16.51 | 16.84 | 16.27 | 0.892 times | 
| 22 Wed Oct 2025 | 16.48 | 18.23 | 18.23 | 16.43 | 0.782 times | 
| 21 Tue Oct 2025 | 17.73 | 17.30 | 18.18 | 17.25 | 0.93 times | 
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 17.6 as stoploss in an intra day sell trade for a target of 16.72. However, stock will show a bullish move above 17.6.
Share price targets for Biohaven Pharmaceutical (BHVN)
| Target Type | Value | 
| Downside Target | 12.79 | 
| Downside Target | 13.40 | 
| Downside Target | 13.87 | 
| Downside Target | 14.63 | 
| Downside Target | 16.00 | 
| Downside Target | 16.80 | 
| Upside Target | 17.25 | 
| Upside Target | 17.61 | 
| Upside Target | 17.73 | 
| Upside Target | 17.84 | 
| Upside Target | 18.08 | 
| Upside Target | 18.23 | 
| Upside Target | 18.57 | 
Intraday share price targets for Biohaven Pharmaceutical (BHVN)
| Target Type | Value | 
| Downside Intraday Target | 16.79 | 
| Downside Intraday Target | 16.37 | 
| Upside Intraday Target | 17.73 | 
| Upside Intraday Target | 18.25 | 
| Upside Intraday Target | 17.31 | 
Weekly technical analysis of Biohaven Pharmaceutical (BHVN)
| Date | Weekly Closing Price | Open | High | Low | Volume | 
| 31 Fri Oct 2025 | 17.20 | 17.20 | 17.84 | 16.90 | 0.242 times | 
| 31 Fri Oct 2025 | 17.20 | 16.90 | 18.57 | 16.80 | 1.049 times | 
| 24 Fri Oct 2025 | 16.60 | 16.58 | 18.23 | 16.27 | 0.816 times | 
| 17 Fri Oct 2025 | 16.07 | 16.00 | 18.08 | 14.83 | 1.036 times | 
| 10 Fri Oct 2025 | 15.80 | 16.12 | 17.61 | 14.98 | 1.415 times | 
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Biohaven Pharmaceutical (BHVN)
| Date | Monthly Closing Price | Open | High | Low | Volume | 
| 31 Fri Oct 2025 | 17.20 | 14.99 | 18.57 | 14.63 | 0.922 times | 
| 30 Tue Sep 2025 | 15.01 | 15.31 | 17.25 | 13.40 | 1.299 times | 
| 29 Fri Aug 2025 | 15.39 | 14.99 | 16.20 | 12.83 | 0.99 times | 
| 31 Thu Jul 2025 | 15.10 | 14.04 | 16.00 | 12.79 | 1.083 times | 
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Biohaven Pharmaceutical (BHVN)
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Biohaven Pharmaceutical stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Biohaven Pharmaceutical in short term but the sell signal is initial and weak.
Biohaven Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Biohaven Pharmaceutical in short term
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Biohaven Pharmaceutical is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 17.21 and Biohaven Pharmaceutical (BHVN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biohaven Pharmaceutical (BHVN) stock. Volume based technical analysis of Biohaven Pharmaceutical (BHVN) stock is negative.
Biohaven Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Biohaven Pharmaceutical ( (BHVN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Biohaven Pharmaceutical stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Biohaven Pharmaceutical in short term but the sell signal is initial and weak.
Biohaven Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Biohaven Pharmaceutical in short term
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Biohaven Pharmaceutical is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 17.21 and Biohaven Pharmaceutical (BHVN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biohaven Pharmaceutical (BHVN) stock. Volume based technical analysis of Biohaven Pharmaceutical (BHVN) stock is negative.
Biohaven Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

